Back
Garmin Vs. Akero Therapeutics Industry Stock Comparison
Sell
49
GRMN
Garmin
Last Price:
105.72
Seasonality Move:
4.38%
Buy
80
AKRO
Akero Therapeutics
Last Price:
51.68
Seasonality Move:
28.46%
Sell
49
Garmin (GRMN)
is a Sell
Is Garmin a Buy, Sell or Hold?
- The current Garmin [GRMN] share price is $105.43. The Score for GRMN is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- GRMN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $53.24. The Score for AKRO is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $53.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
GRMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.28 | Buy |
| Relative Strength Index (14 RSI): | 59.13 | Buy |
| Chaikin Money Flow: | -458418 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.71 - 105.33) | Buy |
| Bollinger Bands (100): | (96.31 - 102.23) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.4 | Buy |
| Relative Strength Index (14 RSI): | 74.01 | Buy |
| Chaikin Money Flow: | 738899 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.81 - 48.43) | Buy |
| Bollinger Bands (100): | (40.35 - 47.97) | Buy |
GRMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 104.68 | Buy |
| 20-day SMA: | 104.09 | Buy |
| 50-day SMA: | 100.91 | Buy |
| 200-day SMA: | 94.1 | Buy |
| 8-day EMA: | 104.84 | Buy |
| 20-day EMA: | 103.73 | Buy |
| 50-day EMA: | 101.54 | Buy |
| 200-day EMA: | 99.38 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.77 | Buy |
| 20-day SMA: | 46.43 | Buy |
| 50-day SMA: | 43.28 | Buy |
| 200-day SMA: | 40.08 | Buy |
| 8-day EMA: | 48.16 | Buy |
| 20-day EMA: | 46.4 | Buy |
| 50-day EMA: | 44.74 | Buy |
| 200-day EMA: | 38.89 | Buy |
Garmin Earnings Growth & GRMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.51 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.76 per share.
Garmin Technical Analysis
| May-23 | May-24 | May-25 | May-26 | May-30 | May-31 | Jun-1 | Jun-2 | Jun-5 | Jun-6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 24 | 25 | 26 | 30 | 31 | 01 | 02 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| May-23 | May-24 | May-25 | May-26 | May-30 | May-31 | Jun-1 | Jun-2 | Jun-5 | Jun-6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 24 | 25 | 26 | 30 | 31 | 01 | 02 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||